Clinical Trials in Tennessee

Showing 9181-9200 of 20,239 trials

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

NCT01416428

The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

Multiple MyelomaWaldenstrom Macroglobulinemia

Amgen210 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Salinas, California, United States • Denver, Colorado, United States +16 more locations

COMPLETEDPhase 329 miles

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

NCT00358215

The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.

Heart FailureAnemiaCardiovascular Disease+2 more

Amgen2,278 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +751 more locations

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Find Trials by Condition in Tennessee

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Collection and Distribution of Biospecimens for Novel Research

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)